Systematic review of the epidemiological burden of myalgic encephalomyelitis/chronic fatigue syndrome across Europe: Current evidence and EUROMENE research recommendations for epidemiology

Tools

Estévez-López, Fernando, Mudie, Kathleen, Wang-Steverding, Xia ORCID: https://orcid.org/0000-0001-6915-2588, Bakken, Inger Johanne, Ivanovs, Andrejs, Castro-Marrero, Jesús, Nacul, Luis, Alegre, Jose, Zalewski, Paweł, Słomko, Joanna, Strand, Elin Bolle, Pheby, Derek, Shikova, Evelina, Lorusso, Lorenzo, Capelli, Enrica, Sekulic, Slobodan, Scheibenbogen, Carmen, Sepúlveda, Nuno, Murovska, Modra and Lacerda, Eliana and The European Network on ME/CFS (EUROMENE) (2020) Systematic review of the epidemiological burden of myalgic encephalomyelitis/chronic fatigue syndrome across Europe: Current evidence and EUROMENE research recommendations for epidemiology. Journal of Clinical Medicine, 9 (5). ISSN 2077-0383

Full text not available from this repository.

Abstract

This review aimed at determining the prevalence and incidence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in Europe. We conducted a primary search in Scopus, PubMed and Web of Science for publications between 1994 and 15 June 2019 (PROSPERO: CRD42017078688). Additionally, we performed a backward-(reference lists) and forward-(citations) search of the works included in this review. Grey literature was addressed by contacting all members of the European Network on ME/CFS (EUROMENE). Independent reviewers searched, screened and selected studies, extracted data and evaluated the methodological and reporting quality. For prevalence, two studies in adults and one study in adolescents were included. Prevalence ranged from 0.1% to 2.2%. Two studies also included incidence estimates. In conclusion, studies on the prevalence and incidence of ME/CFS in Europe were scarce. Our findings point to the pressing need for well-designed and statistically powered epidemiological studies. To overcome the shortcomings of the current state-of-the-art, EUROMENE recommends that future research is better conducted in the community, reviewing the clinical history of potential cases, obtaining additional objective information (when needed) and using adequate ME/CFS case definitions; namely, the Centers for Disease Control & Prevention−1994, Canadian Consensus Criteria, or Institute of Medicine criteria.

Item Type:	Article
Additional Information:	Funding information: This work was supported by the COST (Action CA 15111: The European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; EUROMENE), the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie [grant agreement no. 707404 to F.E.-L.], the Bulgarian National Science Fund (ДKOCT 01/9 to E.S.). The funders of the present study did not have any role in the design, decision to publish, or preparation of the protocol.
Uncontrolled Keywords:	central nervous system diseases,infections,muscular diseases,post-exertional malaise,virus diseases,medicine(all) ,/dk/atira/pure/subjectarea/asjc/2700
Related URLs:	http://www.scopus.com/inward/record.url?...
Depositing User:	LivePure Connector
Date Deposited:	05 Nov 2024 18:30
Last Modified:	17 Nov 2024 07:30
URI:	https://ueaeprints.uea.ac.uk/id/eprint/97533
DOI:	10.3390/jcm9051557

Actions (login required)

View Item